Personnel Information

写真a

SHIMIZU Norio


Job title

Associate Professor

Laboratory Address

2-3-10 kanda-Surugadai, Chiyoda-ku, Tokyo 101-0062, JAPAN

Mail Address

The inquiry by e-mail is 《here

Degree 【 display / non-display

  • PhD, Tohoku University

Campus Career 【 display / non-display

  • 2015.01
    -
    2017.03
    Tokyo Medical and Dental University, Research and Industry-University Alliance Organization, Center for Stem Cell and Regenerative Medicine, Associate Professor
  • 1996.10
    -
    2014.12
    Tokyo Medical and Dental University, Medical Research Institute, Pathophysiology, Frontier Research Unit Virus Research Unit, Associate Professor
  • 1996.10
    -
    2020.03
    Tokyo Medical and Dental University, Medical Research Institute, Pathophysiology, Pathological Cell Biology, Associate Professor
  • 1996.10
    -
    2020.03
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Bio-Environmental Response, Pathological Cell Biology, Associate Professor
  • 2017.04
     
     
    Tokyo Medical and Dental University, Institute of Research, Division of Advanced Research, Center for Stem Cell and Regenerative Medicine, Associate Professor

display all >>

Research Areas 【 display / non-display

  • Virology

 

Published Papers & Misc 【 display / non-display

  • Yoshimori M, Shibayama H, Imadome KI, Kawano F, Ohashi A, Nishio M, Shimizu N, Kurata M, Fujiwara S, Arai A. Antineoplastic and anti-inflammatory effects of bortezomib on systemic chronic active EBV infection. Blood advances. 2021.04; 5 (7): 1805-1815. ( PubMed, DOI )

  • Nakano S, Tomaru Y, Kubota T, Takase H, Mochizuki M, Shimizu N, Sugita S, Direct Strip PCR Project Groups.. Multiplex solid-phase real-time polymerase chain reaction without DNA extraction: A rapid intraoperative diagnosis using microvolumes. Ophthalmology. 2020.09; - (20): 30933-30937. ( PubMed, DOI )

  • Mizuno M, Endo K, Katano H, Tsuji A, Kojima N, Watanabe K, Shimizu N, Morio T, Sekiya I. The environmental risk assessment of cell-processing facilities for cell therapy in a Japanese academic institution. PloS one. 2020.08; 15 (8): e0236600. ( PubMed, DOI )

  • Nakano S, Tomaru Y, Kubota T, Takase H, Mochizuki M, Shimizu N, Sugita S, Strip PCR Project Group.. Evaluation of a multiplex Strip PCR test for infectious uveitis: a prospective multi-center study. American journal of ophthalmology. 2019.11; 213 (0): 252-259. ( PubMed, DOI )

  • Funakoshi Y, Ito K, Morino S, Kinoshita K, Morikawa Y, Kono T, Doan YH, Shimizu H, Hanaoka N, Konagaya M, Fujimoto T, Suzuki A, Chiba T, Akiba T, Tomaru Y, Watanabe K, Shimizu N, Horikoshi Y. Enterovirus D68 respiratory infection in a children's hospital in Japan in 2015. Pediatrics international : official journal of the Japan Pediatric Society. 2019.05; ( PubMed, DOI )

display all >>

Conference Activities & Talks 【 display / non-display

  • Yoshimori M, Shixing Wu, Tateishi M, Ohashi A, Shimizu N, Imadome K, Arai A. The expression and function of EBV-derived micro-RNA in chronic active EBV infection(慢性活動性EBウイルス感染症におけるウイルス由来マイクロRNAの発現と機能). 第81回日本血液学会学術集会 2019.10.11 東京

  • Sugita N, Takase H, Nakako S, Takarano A, Tomaru Y, Shimizu N, Mochizuki M.. PCR diagnostic of uveitis.. 2th Annual Congress of Japan Clinical Ophthalmology. 2018.10.11 Tokyo Japan.

  • Watanabe k, Shimada H, Yunomae Y, Shimizu N, Sekiya I. . Ensuring microbiol safety in regenerative medicine: Development of rapid detection method for live or dead bacteria selection.. 17th The Japanese Society for Regenerative Medicine 2018.03.21 Yokohama,Japan.

  • Haruna Shibayama, Ken-ichi Imadome, Chizuko Sakashita, Ken Watanabe, Fuyuko Kawano, Norio Shimizu, Takatoshi Koyama, Shigeyoshi Fujiwara, Osamu Miura, Ayako Arai. In vitro and in vivo effects of bortezomib on EBV-T/NK-LPDs. The 78th Annual Meeting of the Japanese Society of Hematology 2016.10.14 Yokohama

  • Haruna Shibayama, Ken-ichi Imadome, Chizuko Sakashita, Ken Watanabe, Norio Shimizu, Takatoshi Koyama, Shigeyoshi Fujiwara, Osamu Miura, Ayako Arai. In vitro and in vivo effects of proteasome inhibitor bortezomib on Epstein-Barr virus-positive T- or NK-cell lymphoproliferative diseases. 17th International Symposium on Epstein-Barr virus (EBV) and Associated Diseases 2016.08.10 Zurich

Patents 【 display / non-display

  • METHOD FOR DETECTING AND QUANTIFYING TARGET NUCLEIC ACID IN TEST SAMPLE USING NOVEL POSITIVE CONTROL NUCLEIC ACID

    Patent Number: EP3208333

  • METHOD FOR DETECTING MYCOPLASMA

    Patent Number: US10640834

  • METHOD FOR DETECTING MYCOPLASMA

    Patent Number: 3192878